A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancer.
Ahmann, D L
A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancer. [electronic resource] - American journal of clinical oncology Jun 1991 - 179-83 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0277-3732
10.1097/00000421-199106000-00001 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Middle Aged
Prednisone--administration & dosage
Soft Tissue Neoplasms--secondary
Survival Rate
A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancer. [electronic resource] - American journal of clinical oncology Jun 1991 - 179-83 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0277-3732
10.1097/00000421-199106000-00001 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Middle Aged
Prednisone--administration & dosage
Soft Tissue Neoplasms--secondary
Survival Rate